1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Institut d'Oncologia – VHIO
  4. Articles científics - VHIO
  5. View Item

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Author

Rejeski, Kai

Villacampa Javierre, Guillermo

van Doesum, Jaap

CHIAPPELLA, ANNALISA

Bonifazi, Francesca

Marin Niebla, Ana

Barba, Pere

IACOBONI, GLORIA

Camacho-Arteaga, Lina

Other authors

Institut Català de la Salut

[Iacoboni G, Marín-Niebla A, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rejeski K] Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. [Villacampa G] Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. The Institute of Cancer Research, London, United Kingdom. [van Doesum JA] Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. [Chiappella A] Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy. [Bonifazi F] IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seragnoli”, Bologna, Italy. [Camacho-Arteaga L] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Farmacologia Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-05-24T11:38:24Z

2023-05-24T11:38:24Z

2022-06-28

Share

Abstract

Treatment; Mantle cell lymphoma; Relapsed

Tractament; Limfoma de cèl·lules del mantell; Recaiguda

Tratamiento; Linfoma de células del manto; Recaída

Document Type

Article

Published version

Language

English

Subjects and keywords

Teràpia cel·lular; Limfomes - Tractament; DISEASES::Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, Mantle-Cell; Other subheadings::Other subheadings::Other subheadings::/drug therapy; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Immunologic Techniques::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive; ENFERMEDADES::neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células del manto; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas inmunológicas::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva

Publisher

American Society of Hematology

Related items

Blood Advances;6(12)

https://doi.org/10.1182/bloodadvances.2021006922

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3439]

Articles científics - VHIR [1665]